Breakout
Date & Time:
March 23, 2025
10:30 AM – 12:00 PM ET
Format:
In Person & Virtual
CE Credits:
1.5 Hours
UAN: JA0002345-0000-25-028-L01-P
Course level:
Intermediate/Advanced
Pediatric Content
What You'll Learn
LEARNING OBJECTIVES
- Identify the indications for glucagon-like peptide-2 (GLP-2) use in intestinal failure.
- Evaluate data on GLP-2 to guide evidence-based decision making in clinical practice.
- Develop strategies for weaning parenteral nutrition (PN) and advancing oral and enteral nutrition.
- Enhance understanding of the real-world impact of GLP-2 therapy.
Topics & Presenters
GLP-2 Therapies: Effectiveness and Safety
Director of the Intestinal Rehabilitation Program
University of Nebraska Medical Center
Professor of Surgery
Division of Transplant Surgery, University of Nebraska Medical Center
From Clinical Trials to Clinical Practice: Real-World Impact of GLP-2 Therapy
Director, Pediatric Intestinal Rehabilitation Center
Columbia University Irving Medical Center
Assistant Professor of Pediatrics
Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Columbia University Irving Medical Center
Practical Strategies for Weaning Parenteral Nutrition and Advancing Oral and Enteral Nutrition
Pediatric Nutrition Support Dietitian
NewYork-Presbyterian Morgan Stanley Children’s Hospital
Moderators:
Sivan Kinberg
MDDirector, Pediatric Intestinal Rehabilitation Center
Columbia University Irving Medical Center
Assistant Professor of Pediatrics
Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Columbia University Irving Medical Center